The guests of the special edition of the Patient Week are: prof. Konrad Rejdak, president of the Polish Neurological Society and Malina Wieczorek, president of the SM-Walcz o Siebie Foundation.
In the conversation we asked about this:
- what are the benefits of subcutaneous administration? In the drug program B.46, in the second line, natalizumab is used - a drug with proven effectiveness an...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
